HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.

Abstract
Macrophage migration inhibitory factor (MIF) has been shown to promote disease progression in many malignancies, including multiple myeloma (MM). We previously reported that MIF regulates MM bone marrow homing and knockdown of MIF favors the extramedullary myeloma formation in mice. Here, based on MIF immunostaining of myeloma cells in paired intramedullary and extramedullary biopsies from 17 patients, we found lower MIF intensity in extramedullary MM (EMM) versus intramedullary MM (IMM). Flow cytometry and histology analysis in xenograft models showed a portion of inoculated human MM cells lost their MIF expression (MIFLow) in vivo. Of note, IMM had dominantly MIFHigh cells, while EMM showed a significantly increased ratio of MIFLow cells. Furthermore, we harvested the extramedullary human MM cells from a mouse and generated single-cell transcriptomic data. The developmental trajectories of MM cells from the MIFHigh to MIFLow state were indicated. The MIFHigh cells featured higher proliferation. The MIFLow ones were more quiescent and harbored abundant ribosomal protein genes. Our findings identified in vivo differential regulation of MIF expression in MM and suggested a potential pathogenic role of MIF in the extramedullary spread of disease.
AuthorsJuan Xu, Nanhui Yu, Pan Zhao, Fangfang Wang, Jingcao Huang, Yushan Cui, Hong Ding, Yan Yang, Yuhan Gao, Ling Pan, Hong Chang, Yu Wu, Bing Xiang, Yuping Gong, Xiao Shuai, Li Hou, Liping Xie, Ting Niu, Ting Liu, Li Zhang, Weiping Liu, Wenyan Zhang, Ying Qu, Wei Lin, Yimin Zhu, Sha Zhao, Yuhuan Zheng
JournalFrontiers in oncology (Front Oncol) Vol. 11 Pg. 694331 ( 2021) ISSN: 2234-943X [Print] Switzerland
PMID34268123 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Xu, Yu, Zhao, Wang, Huang, Cui, Ding, Yang, Gao, Pan, Chang, Wu, Xiang, Gong, Shuai, Hou, Xie, Niu, Liu, Zhang, Liu, Zhang, Qu, Lin, Zhu, Zhao and Zheng.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: